Halozyme Therapeutics Inc (HALO)
59.18
-1.25
(-2.07%)
USD |
NASDAQ |
Oct 04, 16:00
59.21
+0.03
(+0.05%)
After-Hours: 20:00
Halozyme Therapeutics Shareholders Equity (Annual): 83.81M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 83.81M |
| December 31, 2022 | 169.80M |
| December 31, 2021 | 196.95M |
| December 31, 2020 | 151.05M |
| December 31, 2019 | 91.76M |
| December 31, 2018 | 248.89M |
| December 31, 2017 | 208.37M |
| December 31, 2016 | -32.48M |
| December 31, 2015 | 43.00M |
| December 31, 2014 | 41.35M |
| December 31, 2013 | -19.99M |
| December 31, 2012 | 48.85M |
| Date | Value |
|---|---|
| December 31, 2011 | 10.90M |
| December 31, 2010 | 20.35M |
| December 31, 2009 | 6.903M |
| December 31, 2008 | 15.38M |
| December 31, 2007 | 57.77M |
| December 31, 2006 | 23.08M |
| December 31, 2005 | 18.21M |
| December 31, 2004 | 14.82M |
| December 31, 2003 | 0.3738M |
| December 31, 2002 | -0.3796M |
| December 31, 2001 | 0.0228M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
83.81M
Minimum
2023
196.95M
Maximum
2021
138.67M
Average
151.05M
Median
2020
Shareholders Equity (Annual) Benchmarks
| Moderna Inc | 13.85B |
| Azenta Inc | 2.534B |
| Neurocrine Biosciences Inc | 2.232B |
| Insulet Corp | 732.70M |
| Myomo Inc | 8.989M |